These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9601836

  • 21. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
    Vasil'ev IuV, Li IA.
    Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [The endoscopic assessment of the effect of ranitidine and pirenzepine on the manifestations of the gastropathy induced by nonsteroidal anti-inflammatory preparations].
    Karateev AE, Murav'ev IuV, Nasonova VA.
    Ter Arkh; 1997; 69(5):67-9. PubMed ID: 9235663
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prevention of NSAID-induced ulcers.
    Lawless C, Force RW.
    J Fam Pract; 1996 Sep; 43(3):239-40. PubMed ID: 8797749
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prostaglandins in peptic ulceration.
    Fenn GC.
    Br J Hosp Med; 1996 Sep; 48(11):776. PubMed ID: 1361396
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
    Vakhrushev IaM, Loshchakova OIu.
    Eksp Klin Gastroenterol; 2007 Sep; (1):60-3, 71. PubMed ID: 17547116
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T, Sasaki M, Kataoka H, Tanida S, Itoh K, Ogasawara N, Oshima T, Togawa S, Kubota E, Yamada T, Mori Y, Fujita F, Ohara H, Nakao H, Sobue S, Joh T, Itoh M.
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
    [Abstract] [Full Text] [Related]

  • 32. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B, Xia HH, Ma CW, Wong KW, Fung FM, Hui CK, Chan CK, Chan AO, Lai KC, Yuen MF, Wong BC.
    Aliment Pharmacol Ther; 2005 Aug 01; 22(3):243-9. PubMed ID: 16091062
    [Abstract] [Full Text] [Related]

  • 33. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
    Yamaguchi Y, Katsumi N, Tauchi M, Toki M, Nakamura K, Aoki K, Morita Y, Miura M, Morozumi K, Ishida H, Takahashi S.
    Aliment Pharmacol Ther; 2005 Jun 01; 21 Suppl 2():111-5. PubMed ID: 15943857
    [Abstract] [Full Text] [Related]

  • 34. [Clinical aspects of Kvamatel (famotidine) administration].
    Golochevskaia VS.
    Klin Med (Mosk); 1996 Jun 01; 74(1):45-7. PubMed ID: 8649009
    [No Abstract] [Full Text] [Related]

  • 35. [Therapeutic protocol in ulcers due to non-steroidal anti-inflammatory drugs].
    van Berge Henegouwen GP, Bijlsma JW.
    Ned Tijdschr Geneeskd; 1991 Mar 23; 135(12):504-8. PubMed ID: 1674108
    [No Abstract] [Full Text] [Related]

  • 36. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y, Higuchi K, Nebiki H, Chono S, Uno H, Kitada K, Satoh H, Nakagawa K, Kobayashi K, Tominaga K, Watanabe T, Oshitani N, Arakawa T.
    Aliment Pharmacol Ther; 2005 Jun 23; 21 Suppl 2():10-8. PubMed ID: 15943841
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Efficiency of famotidin in prophylaxis of NSAIDs-induced gastropathy: result of multicenter research ZASLON-1 (protection of gastric mucosa from non-steroidal anti-inflammatory drugs].
    Lazebnik LB, Drozdov VN, Kim VA.
    Eksp Klin Gastroenterol; 2009 Jun 23; (2):3-9. PubMed ID: 19552017
    [Abstract] [Full Text] [Related]

  • 39. Drug-induced gastropathy in elderly Taiwanese.
    Wu KL, Liou SH, Lay CS.
    Hepatogastroenterology; 2000 Jun 23; 47(32):596-600. PubMed ID: 10791246
    [Abstract] [Full Text] [Related]

  • 40. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.
    J Rheumatol; 2002 Mar 23; 29(3):467-73. PubMed ID: 11908558
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.